Romiplostim, a TPO‐RA, is used in human patients with refractory ITP (defined as those who have failed corticosteroid and immunoglobulin treatment and have been splenectomized), or to bridge the gap before splenectomy can be performed [11]. This evidence concerns the gene TPO and autoimmune thrombocytopenic purpura.